Persistence of Immunity Against Hepatitis B in 12-13 Year Old Adolescents After Infant Hepatitis B Vaccination
Clinical trial NCT00984139 · COMPLETED
Trial details
- NCT number
- NCT00984139
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2009-10-12
- Primary completion
- 2010-04-07
- Enrollment
- 306
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.